C12Y 203/01006
Choline o-acetyltransferase
Official title: Choline O-acetyltransferase (2.3.1.6)
C12Y203/01006 (Choline o-acetyltransferase) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 7
- Inventors
- 28
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Expression systems and methods of use thereof18 Feb 2025US 12,227,771 B2Janssen Pharmaceutica NV
- Choline acetyltransferase as a therapy for hypertension8 Oct 2024US 12,109,255 B2The Feinstein Institutes for Medical Research
- Methods of treating hypertension12 Apr 2022US 11,298,408 B2The Feinstein Institutes for Medical Research
- Human neural stem cells expressing human choline acetyltransferase, and use thereof2 Feb 2016US 9,248,152 B2Chungbuk National University Industry-Academic Cooperation Foundation
- Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system9 Jun 1998US 5,762,926 AThe Regents of the University of California
- Alzheimer's disease gene therapeutics and methods of use thereof29 Jan 2026US 2026/0027234 A1Florida Atlantic University Board of Trustees
- Expression systems for the alpha2alpha5beta2 nicotinic acetylcholine receptor and methods of use thereof11 Sep 2025US 2025/0283872 A1
- Expression systems for the alpha6beta4 nicotinic acetylcholine receptor and methods of use thereof4 Sep 2025US 2025/0277784 A1
- Expression systems for the alpha6-containing nicotinic acetylcholine receptor and methods of use thereof12 Jun 2025US 2025/0189514 A1
- Choline acetyltransferase as a therapy for endotoxemia, sepsis, colitis and inflammatory diseases6 Mar 2025US 2025/0073317 A1The Feinstein Institutes for Medical Research
Most cited
By later US patents
- Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system50US 5,650,148 AThe Regents of the University of California · 1997
- Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system43US 5,762,926 AThe Regents of the University of California · 1998
- Methods of treating hypertension1US 11,298,408 B2The Feinstein Institutes for Medical Research · 2022